content: <html>
  <head>
       <title></title>
  </head>
  <BODY STYLE="font-size: 10pt">
  
  <p style="margin: 0"></P>
  
  <P STYLE="font: 12pt/0.05pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (date of earliest event reported):
  <B>December 30, 2016</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Kaya Holdings, Inc.</B></P>
  
  <P STYLE="margin: 0; text-align: center">(Exact name of registrant as specified in charter)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Delaware</B></P>
  
  <P STYLE="margin: 0; text-align: center">(State or other jurisdiction of incorporation)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 50%; border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>333-177532</B></FONT></TD>
      <TD STYLE="width: 3%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 47%; border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">900898007</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(Commission
      File Number)</FONT></TD>
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
      Employer Identification No.)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>305
  S. Andrews Avenue, Suite 209, Fort Lauderdale, Florida 33301</B></FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;(Address
  of principal executive offices and zip code)</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(954)
      534-7895</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
      telephone number including area code)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former
      Name or Former Address (If Changed Since Last Report)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 2%; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 4%; padding-right: 0.8pt; text-align: justify">[ ]</TD>
      <TD STYLE="margin: 0; text-align: justify; width: 94%">Written communications pursuant to Rule 425 under the Securities
      Act (17 CFR 230.425)</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 2%; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 4%; padding-right: 0.8pt; text-align: justify">[ ]</TD>
      <TD STYLE="margin: 0; text-align: justify; width: 94%">Soliciting material pursuant to Rule 14a-12(b) under the
      Exchange Act (17 CFR 240.14a-12)</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 2%; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 4%; padding-right: 0.8pt; text-align: justify">[ ]</TD>
      <TD STYLE="margin: 0; text-align: justify; width: 94%">Pre-commencement communications pursuant to Rule 14d-2(b)
      under the Exchange Act (17 CFR 240.14d-2(b))&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 2%; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 4%; padding-right: 0.8pt; text-align: justify">[ ]</TD>
      <TD STYLE="margin: 0; text-align: justify; width: 94%">Pre-commencement communications pursuant to Rule 13e-4(c)
      under the Exchange Act (17&nbsp;CFR&nbsp;240.13e-4(c))</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>
  
  <P STYLE="font: 12pt/6pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt/0.05pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
      <TD STYLE="width: 100%; padding-right: 0.8pt; text-align: center">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: justify">As used in this Current Report on Form 8-K
  and unless otherwise indicated, the terms &ldquo;<B>KAYS</B>,&rdquo; &ldquo;<B>the</B> <B>Company</B>,&rdquo; &ldquo;<B>we</B>,&rdquo;
  &ldquo;<B>us</B>&rdquo; and &ldquo;<B>our</B>&rdquo; refer to Kaya Holdings, Inc. and its subsidiaries.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 1.01.&#9;Entry Into a Material Definitive Agreement.</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify">The disclosure set forth below under &ldquo;<B>Item
  3.02.</B> <B>Unregistered Sales of Equity Securities&rdquo; </B>is hereby incorporated by reference into this <B>Item 1.01</B>.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 3.02.&#9;Unregistered Sales of Equity
  Securities.</B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">On December 30, 2016, we entered into a $2.1 million financing agreement (the &ldquo;<B>Financing Agreement</B>&rdquo;) with an institutional investor (the &ldquo;<B>Investor</B>&rdquo;) who had previously
  furnished KAYS with $1.2 million in financing, pursuant to which the Investor purchased and agreed to purchase up to $2.1 million
  in convertible notes (the &ldquo;<B>Notes</B>&rdquo;) from the Company as follows:</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&#183;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">The Investor purchased $250,000 in principal amount of Notes from the Company on December
  31, 2016, contemporaneously with the execution of the Financing Agreement, which Notes are convertible into shares of the
  Company&rsquo;s common stock (&ldquo;<B>Shares</B>&rdquo;), at a conversion price of $0.04.(the &ldquo;<B>$0.04 Notes</B>&rdquo;).</TD>
  </TR></TABLE>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&#183;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">The Investor purchased an additional $150,000 in principal amount of $0.04 Notes from
  the Company on January 4, 2017.</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&#183;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">The Investor has the right to purchase up to an aggregate of an additional $700,000
  in principal amount of Notes at any time and from time to time through March 31, 2017, which Notes will be convertible into Shares
  at a conversion price of $0.07 (the <B>&ldquo;$0.07 Notes</B>&rdquo;).</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right">&#183;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Provided the Investor has fulfilled its obligation to purchase all $700,000 in principal
  amount of $0.07 Notes from the Company on or before March 31, 2017, the Investor will have the right to purchase up to an aggregate
  of up to an additional $1,000,000 in principal amount of Notes at any time and from time to time through June 30, 2017, which
  Notes will be convertible into Shares at a conversion price of $0.10.</TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify"></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">The purchase price for the Notes is equal
  to the principal amount thereof. The Notes have a term of two years from issuance and bear interest at the rate of eight percent
  (8%) annum, which accrues and is payable to together with interest at maturity. The Investor may convert the principal amount
  of the Notes (as well as other notes it currently holds as referenced above), together with accrued but unpaid interest thereon,
  into Shares at the applicable conversion price, at any time or from time to time prior to maturity. The conversion price is subject
  to adjustment for stock splits, stock dividends, recapitalizations and similar transactions. The Notes also provide that at no
  time may they be convertible if the number of Shares being issued upon conversion to and then held by the Investor would result
  in the Investor beneficially owning in excess of 4.99% of the Company&rsquo;s then outstanding Shares, after giving effect to
  the proposed conversion.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"></P>
  
  <P STYLE="margin: 0; text-align: justify">The Financing Agreement also provided that in consideration of the Company and
  Investor entering into the Financing Agreement, the currently outstanding $1,051,825 in principal amount of Notes previously
  made by the Company in favor of Purchaser (the &ldquo;<B>Prior Notes</B>&rdquo;) are modified and amended to (a) extend
  the maturity date of the Prior Notes is hereby extended to January 1, 2019 (the &ldquo;<B>Extended Maturity Date</B>&rdquo;);
  and (b) reduce the, the interest rate on the Prior Notes is hereby reduced to eight percent (8%) per annum until the
  Extended Maturity Date. In addition, Investor waived the right to acquire an additional $250,000 in principal amount of
  Notes pursuant to arrangements entered into with the Company prior to the date of  Financing Agreement.</P>
  
  
  
  <P STYLE="margin: 0; text-align: justify"></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"></P>
  
  <P STYLE="margin: 0; text-align: justify">The Notes are being issued pursuant to the exemption
  from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended and Regulation D thereunder. No commissions
  or placement fees were paid in connection with the offer and sale of the Notes. The proceeds from the offer and sale of Notes
  will be used to fund the Company&rsquo;s 2017 growth plan, including expansion of our chain of legal Kaya Shack&trade; Marijuana
  Superstores in Oregon, increasing the capacity of our legal marijuana grow facility and manufacturing operations and introducing
  new Kaya branded cannabis products.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Copies of the Financing Agreement and the form
  of Note attached hereto as <B>Exhibit 10.1</B> and <B>Exhibit 10.2</B>, respectively, and are incorporated herein by reference.
  The foregoing summaries do not purport to be complete and are qualified in their entirety by reference to such documents.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 9.01&#9;Financial Statements and Exhibits.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Exhibits</TD></TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0 66pt">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
  <TR STYLE="vertical-align: top">
  <TD STYLE="width: 10%"><B><U>Exhibit No.</U></B></TD><TD STYLE="text-align: justify; width: 90%"><B><U>Description</U></B></TD></TR>
  <TR STYLE="vertical-align: top">
  <TD>10.1</TD><TD STYLE="text-align: justify"><A HREF="kays0104178kex10_1.htm">Financing Agreement</A></TD></TR>
  <TR STYLE="vertical-align: top">
  <TD>10.2</TD><TD STYLE="text-align: justify"><A HREF="kays0104178kex10_2.htm">Form of Note</A></TD></TR>
  </TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0 66pt"><B>&nbsp;</B>&nbsp;</P>
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>SIGNATURE</B></P>
  
  
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Pursuant to the requirements
  of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
  hereunto duly authorized.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD COLSPAN="2" STYLE="padding-right: 1.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KAYA
      HOLDINGS, INC.</B></FONT></TD>
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 51%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 4%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 43%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 2%; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:&nbsp;&nbsp;January
      6, 2017</FONT></TD>
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
      <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&nbsp;Craig
      Frank</FONT></TD>
      <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: top; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Craig
      Frank, President and Chief Executive Officer</FONT></TD>
      <TD STYLE="vertical-align: top; padding-right: 0.8pt">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
  
  
  
  <P STYLE="margin: 0"></P>
  
  <!-- Field: Page; Sequence: 4; Options: Last -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0">&#160;</p>
  
  </body>
  </html>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "kays0104178k.htm", "secsgml_size_bytes": 24168}]
metadata_filer: {"company-data": {"conformed-name": "Kaya Holdings, Inc.", "cik": "0001530746", "assigned-sic": "2834", "irs-number": "900898007", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-177532", "film-number": "17512880"}, "business-address": {"street1": "305 SOUTH ANDREWS AVENUE", "street2": "SUITE 209", "city": "FORT LAUDERDALE", "state": "FL", "zip": "33301", "phone": "954-5347895"}, "mail-address": {"street1": "305 SOUTH ANDREWS AVENUE", "street2": "SUITE 209", "city": "FORT LAUDERDALE", "state": "FL", "zip": "33301"}, "former-company": [{"former-conformed-name": "Alternative Fuels Americas, Inc.", "date-changed": "20120125"}, {"former-conformed-name": "Alternative Fuels America, Inc.", "date-changed": "20110921"}]}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  WASHINGTON, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934
  Date of Report (date of earliest event reported):
  December 30, 2016
  Kaya Holdings, Inc.
  (Exact name of registrant as specified in charter)
  Delaware
  (State or other jurisdiction of incorporation)
  333-177532
  900898007
  (Commission
      File Number)
  (IRS
      Employer Identification No.)
  305
  S. Andrews Avenue, Suite 209, Fort Lauderdale, Florida 33301
  (Address
  of principal executive offices and zip code)
  (954)
      534-7895
  (Registrant's
      telephone number including area code)
  Former
      Name or Former Address (If Changed Since Last Report)
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
  [ ]
  Written communications pursuant to Rule 425 under the Securities
      Act (17 CFR 230.425)
  [ ]
  Soliciting material pursuant to Rule 14a-12(b) under the
      Exchange Act (17 CFR 240.14a-12)
  [ ]
  Pre-commencement communications pursuant to Rule 14d-2(b)
      under the Exchange Act (17 CFR 240.14d-2(b))
  [ ]
  Pre-commencement communications pursuant to Rule 13e-4(c)
      under the Exchange Act (17 CFR 240.13e-4(c))
  As used in this Current Report on Form 8-K
  and unless otherwise indicated, the terms "
  KAYS
  ," "
  the
  Company
  ," "
  we
  ,"
  "
  us
  " and "
  our
  " refer to Kaya Holdings, Inc. and its subsidiaries.
  Item 1.01.	Entry Into a Material Definitive Agreement.
  The disclosure set forth below under "
  Item
  3.02.
  Unregistered Sales of Equity Securities"
  is hereby incorporated by reference into this
  Item 1.01
  .
  Item 3.02.	Unregistered Sales of Equity
  Securities.
  On December 30, 2016, we entered into a $2.1 million financing agreement (the "
  Financing Agreement
  ") with an institutional investor (the "
  Investor
  ") who had previously
  furnished KAYS with $1.2 million in financing, pursuant to which the Investor purchased and agreed to purchase up to $2.1 million
  in convertible notes (the "
  Notes
  ") from the Company as follows:
  ·
  The Investor purchased $250,000 in principal amount of Notes from the Company on December
  31, 2016, contemporaneously with the execution of the Financing Agreement, which Notes are convertible into shares of the
  Company's common stock ("
  Shares
  "), at a conversion price of $0.04.(the "
  $0.04 Notes
  ").
  ·
  The Investor purchased an additional $150,000 in principal amount of $0.04 Notes from
  the Company on January 4, 2017.
  ·
  The Investor has the right to purchase up to an aggregate of an additional $700,000
  in principal amount of Notes at any time and from time to time through March 31, 2017, which Notes will be convertible into Shares
  at a conversion price of $0.07 (the
  "$0.07 Notes
  ").
  ·
  Provided the Investor has fulfilled its obligation to purchase all $700,000 in principal
  amount of $0.07 Notes from the Company on or before March 31, 2017, the Investor will have the right to purchase up to an aggregate
  of up to an additional $1,000,000 in principal amount of Notes at any time and from time to time through June 30, 2017, which
  Notes will be convertible into Shares at a conversion price of $0.10.
  The purchase price for the Notes is equal
  to the principal amount thereof. The Notes have a term of two years from issuance and bear interest at the rate of eight percent
  (8%) annum, which accrues and is payable to together with interest at maturity. The Investor may convert the principal amount
  of the Notes (as well as other notes it currently holds as referenced above), together with accrued but unpaid interest thereon,
  into Shares at the applicable conversion price, at any time or from time to time prior to maturity. The conversion price is subject
  to adjustment for stock splits, stock dividends, recapitalizations and similar transactions. The Notes also provide that at no
  time may they be convertible if the number of Shares being issued upon conversion to and then held by the Investor would result
  in the Investor beneficially owning in excess of 4.99% of the Company's then outstanding Shares, after giving effect to
  the proposed conversion.
  The Financing Agreement also provided that in consideration of the Company and
  Investor entering into the Financing Agreement, the currently outstanding $1,051,825 in principal amount of Notes previously
  made by the Company in favor of Purchaser (the "
  Prior Notes
  ") are modified and amended to (a) extend
  the maturity date of the Prior Notes is hereby extended to January 1, 2019 (the "
  Extended Maturity Date
  ");
  and (b) reduce the, the interest rate on the Prior Notes is hereby reduced to eight percent (8%) per annum until the
  Extended Maturity Date. In addition, Investor waived the right to acquire an additional $250,000 in principal amount of
  Notes pursuant to arrangements entered into with the Company prior to the date of  Financing Agreement.
  The Notes are being issued pursuant to the exemption
  from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended and Regulation D thereunder. No commissions
  or placement fees were paid in connection with the offer and sale of the Notes. The proceeds from the offer and sale of Notes
  will be used to fund the Company's 2017 growth plan, including expansion of our chain of legal Kaya Shack™ Marijuana
  Superstores in Oregon, increasing the capacity of our legal marijuana grow facility and manufacturing operations and introducing
  new Kaya branded cannabis products.
  Copies of the Financing Agreement and the form
  of Note attached hereto as
  Exhibit 10.1
  and
  Exhibit 10.2
  , respectively, and are incorporated herein by reference.
  The foregoing summaries do not purport to be complete and are qualified in their entirety by reference to such documents.
  Item 9.01	Financial Statements and Exhibits.
  (a)
  Exhibits
  Exhibit No.
  Description
  10.1
  Financing Agreement
  10.2
  Form of Note
  SIGNATURE
  Pursuant to the requirements
  of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
  hereunto duly authorized.
  KAYA
      HOLDINGS, INC.
  Date:  January
      6, 2017
  By:
  /s/ Craig
      Frank
  Craig
      Frank, President and Chief Executive Officer